Se Kyoo Jeong1, Young Il Kim2, Kyong-Oh Shin3, Bong-Woo Kim4, Sin Hee Lee4, Jeong Eun Jeon4, Hyun Jong Kim5, Yong-Moon Lee3, Theodora M Mauro2, Peter M Elias2, Yoshikazu Uchida6, Kyungho Park7. 1. CRID center, NeoPharm Co., Ltd., Daejeon 305-510, South Korea; College of Pharmacy, Chungbuk National University, Cheongju 361-763, South Korea. 2. Department of Dermatology, School of Medicine, University of California, San Francisco, CA 94158, USA; Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA; Northern California Institute for Research and Education, San Francisco, CA 94121, USA. 3. College of Pharmacy, Chungbuk National University, Cheongju 361-763, South Korea. 4. CRID center, NeoPharm Co., Ltd., Daejeon 305-510, South Korea. 5. Department of Dermatology and Atopy Clinic, Seoul Medical Center, Seoul 131-865, South Korea. 6. Department of Dermatology, School of Medicine, University of California, San Francisco, CA 94158, USA; Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA; Northern California Institute for Research and Education, San Francisco, CA 94121, USA. Electronic address: uchiday@derm.ucsf.edu. 7. Department of Dermatology, School of Medicine, University of California, San Francisco, CA 94158, USA; Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA; Northern California Institute for Research and Education, San Francisco, CA 94121, USA. Electronic address: parkk@derm.ucsf.edu.
Abstract
BACKGROUND: The ceramide metabolite, sphingosine-1-phosphate (S1P), regulates multiple cellular functions in keratinocytes (KC). We recently discovered that production of a key innate immune element, cathelicidin antimicrobial peptide (CAMP), is stimulated via a NF-κB-dependent mechanism that is activated by S1P when S1P is generated by sphingosine kinase (SPHK) 1. OBJECTIVE: We investigated whether pharmacological modulation of SPHK1 activity, using a novel synthetic SPHK1 activator, (S)-methyl 2-(hexanamide)-3-(4-hydroxyphenyl) propanoate (MHP), stimulates CAMP expression. METHODS: MHP-mediated changes in both S1P and CAMP downstream mediators were analyzed in normal cultured human KC by qRT-PCR, Western immunoblot, ELISA, confocal microscopy for immunohistochemistry, HPLC and ESI-LC/MS/MS, and microbial pathogen invasion/colonization in a human epidermal organotypic model. RESULTS: Treatment with MHP directly activated SPHK1 and increased cellular S1P content in normal cultured human KC. Because MHP did not inhibit S1P lyase activity, which hydrolyses S1P, augumented S1P levels could be attributed to increased synthesis rather than blockade of S1P degradation. Next, we found that exogenous MHP significantly stimulated CAMP mRNA and protein production in KC, increases that were significantly suppressed by siRNA directed against SPHK1, but not by a scrambled control siRNA. NF-κB activation, assessed by nuclear translocation of NF-κB, occurred in cells following incubation with MHP. Conversely, pretreatment with a specific inhibitor of SPHK1 decreased MHP-induced nuclear translocation of NF-κB, and significantly attenuated the MHP-mediated increase in CAMP production. Finally, topical MHP significantly suppressed invasion of the virulent Staphylococcus aureus into murine skin explants. CONCLUSION: MHP activation of SPHK1, a target enzyme of CAMP production, can stimulate innate immunity.
BACKGROUND: The ceramide metabolite, sphingosine-1-phosphate (S1P), regulates multiple cellular functions in keratinocytes (KC). We recently discovered that production of a key innate immune element, cathelicidin antimicrobial peptide (CAMP), is stimulated via a NF-κB-dependent mechanism that is activated by S1P when S1P is generated by sphingosine kinase (SPHK) 1. OBJECTIVE: We investigated whether pharmacological modulation of SPHK1 activity, using a novel synthetic SPHK1 activator, (S)-methyl 2-(hexanamide)-3-(4-hydroxyphenyl) propanoate (MHP), stimulates CAMP expression. METHODS:MHP-mediated changes in both S1P and CAMP downstream mediators were analyzed in normal cultured human KC by qRT-PCR, Western immunoblot, ELISA, confocal microscopy for immunohistochemistry, HPLC and ESI-LC/MS/MS, and microbial pathogen invasion/colonization in a human epidermal organotypic model. RESULTS: Treatment with MHP directly activated SPHK1 and increased cellular S1P content in normal cultured human KC. Because MHP did not inhibit S1P lyase activity, which hydrolyses S1P, augumented S1P levels could be attributed to increased synthesis rather than blockade of S1P degradation. Next, we found that exogenous MHP significantly stimulated CAMP mRNA and protein production in KC, increases that were significantly suppressed by siRNA directed against SPHK1, but not by a scrambled control siRNA. NF-κB activation, assessed by nuclear translocation of NF-κB, occurred in cells following incubation with MHP. Conversely, pretreatment with a specific inhibitor of SPHK1 decreased MHP-induced nuclear translocation of NF-κB, and significantly attenuated the MHP-mediated increase in CAMP production. Finally, topical MHP significantly suppressed invasion of the virulent Staphylococcus aureus into murine skin explants. CONCLUSION:MHP activation of SPHK1, a target enzyme of CAMP production, can stimulate innate immunity.
Authors: Seung P Hong; Min J Kim; Min-Young Jung; Hyerin Jeon; Jawoong Goo; Sung K Ahn; Seung H Lee; Peter M Elias; Eung H Choi Journal: J Invest Dermatol Date: 2008-06-26 Impact factor: 8.551
Authors: Jong-Kyung Youm; Hae Jo; Jeong Hee Hong; Dong Min Shin; Mi Jung Kwon; Se Kyoo Jeong; Byeong Deog Park; Eung Ho Choi; Seung Hun Lee Journal: J Dermatol Sci Date: 2008-04-16 Impact factor: 4.563
Authors: Karim M Aloul; Josefine Eilsø Nielsen; Erwin B Defensor; Jennifer S Lin; John A Fortkort; Mehrdad Shamloo; Jeffrey D Cirillo; Adrian F Gombart; Annelise E Barron Journal: Front Immunol Date: 2022-05-12 Impact factor: 8.786
Authors: Kyong-Oh Shin; Dae Hyun Ha; Jin Ock Kim; Debra A Crumrine; Jason M Meyer; Joan S Wakefield; Yerin Lee; Bogyeong Kim; Sungeun Kim; Hyun-Keun Kim; Joon Lee; Hyuck Hoon Kwon; Gyeong-Hun Park; Jun Ho Lee; Jihye Lim; Sejeong Park; Peter M Elias; Kyungho Park; Yong Weon Yi; Byong Seung Cho Journal: Cells Date: 2020-03-10 Impact factor: 6.600
Authors: Nienke M de Wit; Kevin Mol; Sabela Rodríguez-Lorenzo; Helga E de Vries; Gijs Kooij Journal: Front Immunol Date: 2021-01-29 Impact factor: 7.561